Waterman Ventures (an Alumni Ventures Fund)

It feels like just a short pulse ago that the WHAM fusion experiment launched at the University of Wisconsin-Madison. Realta Fusion emerged from that project in 2022 with the goal of commercializing the magnetic mirror concept, raised seed financing in 2023, and fired our first plasma shot in 2024. Today, we announce the next major milestone on our pathway to commercial fusion energy: we have closed a $36 million Series A round to bring this dream even closer to reality. Led by new investor Future Ventures and returning investor Khosla Ventures, this funding will allow us to advance the magnetic mirror beyond a groundbreaking physics experiment and toward a rigorously validated and commercially viable fusion energy system that is as de-risked as you can get it in the lab before you actually go out and build it in the real world. While the work of building compact, scalable, modular fusion energy systems (or CoSMo systems, as we réaltaí call them) waits for no one, for a brief moment we pause to mark the culmination of 5 years of intense and uncompromising work and thank the countless individuals involved who have committed themselves to no less than recreating the power of the sun on planet Earth and the production of clean, reliable, and abundant energy for all humankind. And now, back to work.

Precision Neuroscience is proud to announce that we have received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the Layer 7 Cortical Interface, our high-resolution cortical electrode array, for use in the recording, monitoring, and stimulation of electrical activity on the surface of the brain. This is the first regulatory clearance granted to a company developing a next-generation wireless brain-computer interface (BCI), and marks a pivotal step towards delivering immediate value for patients and neurosurgical teams, enabling real-time neural recording. This clearance allows our array to remain implanted for up to 30 days, opening the door to commercial use in intraoperative surgical mapping and enabling the visualization of brain activity in real time at a fidelity and scale not previously possible. To date, Precision has tested the Layer 7 Cortical Interface in over 35 patients through clinical study partnerships with Mount Sinai Health System, the University of Pennsylvania Perelman School of Medicine, WVU Rockefeller Neuroscience Institute, and Beth Israel Deaconess Medical Center. Additional collaborations are on track to be announced later this year. Read the full new release below for more details on the FDA Clearance. https://lnkd.in/e_PM8jEp

It doesn't get much better than this... Last Friday, Remento landed a deal with Mark Cuban on Shark Tank! 🦈 🎉 The first time I met Mark was on a beach in Miami with some college friends in 2012. After a bit of chit chat, we asked him: “What advice do you have for a few aspiring entrepreneurs?” I'll never forget what he said: “Get off this beach and go build something.” 13 years later, I couldn’t be happier that he'll be helping us reinvent how families preserve their most important memories. Welcome to Team Remento, Mark! 🔗 Link to the full episode in the comments (also watchable on Hulu). ----- For those new to Remento, we help you turn your parent's stories into a keepsake book featuring their voice: 👆 You pick storytelling prompts 📱 They record their spoken answers 📖 Remento turns their recordings into a book of written stories 🤳 Scan the QR codes printed inside to hear their voice For them, it's a memoir that writes itself. And for you, it's their stories and voice, forever at your fingertips. #sharktank #sharktankusa #startups